Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

KV Official Is Excluded From Government Programs, The First Under OIG's New Guidance

This article was originally published in The Pink Sheet Daily

Executive Summary

Former CEO Marc Hermelin resigns from KV's board to prevent the company's exclusion; KV dissolved Ethex under agreement with OIG.

You may also be interested in...



Ranbaxy Fraud Settlement Emphasizes Guilty Pleas, Downplays Exclusion

Although pharmaceutical company settlements in the millions of dollars now seem customary, a guilty plea to seven felonies could signal aggressive government pursuit of manufacturing and data integrity concerns.

OIG Exclusion Power Complicating Consent Decree Negotiations

Companies are having a tougher time negotiating corporate integrity agreements since HHS' Office of Inspector General has intensified its efforts to exclude individuals from federal health care programs.

OIG Exclusion Power Complicating Consent Decree Negotiations

Companies are having a tougher time negotiating corporate integrity agreements since HHS' Office of Inspector General has intensified its efforts to exclude individuals from federal health care programs.

Related Content

Topics

UsernamePublicRestriction

Register

GB150348

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel